The stock's rise snapped a four-day losing streak.

Hologic Inc. has received a warning letter from the Food and Drug Administration regarding its BioZorb product line, even ...

Shares of Hologic Inc. HOLX slid 2.07% to $68.75 Wednesday, on what proved to be an all-around great trading session for the ...

MARLBOROUGH, Mass., January 12, 2025 -- ( BUSINESS WIRE )--Hologic, Inc. (Nasdaq: HOLX) announced today preliminary revenue ...

Hologic stopped manufacturing the device after reports of serious adverse events in patients who had the markers implanted in breast tissue.

On Wednesday, Hologic Inc (HOLX) stock saw a decline, ending the day at $68.75 which represents a decrease of $-1.45 or -2.07% from the prior close of $70.2. The stock opened at $69.97 and touched a ...

Leerink Partners analyst Puneet Souda has maintained their bullish stance on HOLX stock, giving a Buy rating on January 13.Stay Ahead of the ...

Needham analyst Michael Matson maintained a Buy rating on Hologic (HOLX – Research Report) today and set a price target of $90.00.Stay Ahead of ...

With a market cap of $15.9 billion, Marlborough, Massachusetts-based Hologic, Inc. (HOLX) specializes in developing, ...

Hologic Inc (HOLX) stock saw a decline, ending the day at $70.29 which represents a decrease of $-1.41 or -1.97% from the prior close of $71.7. The stock opened at $72.99 and touched a low of $69.46 ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today preliminary revenue results for its first fiscal quarter ended December 28, 2024. The Company expects to report ...

Day 5 of the Australian Open had it all as players battled for a place in the third round. Australian Open: Scores | Schedule | Draws Ons Jabeur taking on Camila Osorio was a match-up for connoisseurs ...